Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Carvalho KIM"'
Autor:
Pinto DP; Laboratory of Pharmacokinetics, Vice Presidency of Research and Innovation in Health - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Coutinho DS; Laboratory of Inflammation, Instituto Oswaldo Cruz - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Carvalho KIM; Laboratory of Inflammation, Instituto Oswaldo Cruz - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Ferrero MR; Laboratory of Inflammation, Instituto Oswaldo Cruz - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Silva LVD; Laboratory of Pharmacokinetics, Vice Presidency of Research and Innovation in Health - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Silveira GPE; Laboratory of Pharmacokinetics, Vice Presidency of Research and Innovation in Health - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Silva DMD; Laboratory of Pharmacokinetics, Vice Presidency of Research and Innovation in Health - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Araújo JFG; Laboratory of Pharmacokinetics, Vice Presidency of Research and Innovation in Health - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Silva ACA; Laboratory of Pharmacokinetics, Vice Presidency of Research and Innovation in Health - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Pereira HM; Laboratory of Pharmacokinetics, Vice Presidency of Research and Innovation in Health - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Fonseca LBD; Laboratory of Pharmacokinetics, Vice Presidency of Research and Innovation in Health - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Faria RX; Laboratory of Toxoplasmosis and Other Protozoans, Oswaldo Cruz Institute, Brazil., Souza MVN; Laboratory of Organic Synthesis, Institute of Technology in Drugs, Farmanguinhos - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Silva ETD; Laboratory of Organic Synthesis, Institute of Technology in Drugs, Farmanguinhos - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Santos-Filho OA; Laboratory of Molecular Modeling and Computational Structural Biology, Instituto de Pesquisas de Produtos Naturais - Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil., Costa JCSD; Vice Presidency of Production and Innovation in Health - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Amendoeira FC; Department of Pharmacology and Toxicology, National Institute of Quality Control in Health - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Martins MA; Laboratory of Inflammation, Instituto Oswaldo Cruz - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. Electronic address: marco.martins@fiocruz.br.
Publikováno v:
European journal of pharmacology [Eur J Pharmacol] 2020 Oct 15; Vol. 885, pp. 173367. Date of Electronic Publication: 2020 Aug 01.
Autor:
Carvalho KIM; Laboratory of Inflammation, Oswaldo Cruz Institute, Rio de Janeiro, Brazil., Coutinho DS; Laboratory of Inflammation, Oswaldo Cruz Institute, Rio de Janeiro, Brazil., Joca HC; Laboratory of Excitable Membranes and Cardiovascular Biology, Federal University of Minas Gerais, Belo Horizonte, Brazil., Miranda AS; Laboratory of Excitable Membranes and Cardiovascular Biology, Federal University of Minas Gerais, Belo Horizonte, Brazil., Cruz JDS; Laboratory of Excitable Membranes and Cardiovascular Biology, Federal University of Minas Gerais, Belo Horizonte, Brazil., Silva ET; Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Souza MVN; Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Faria RX; Laboratory of Toxoplasmosis and Other Protozoans, Oswaldo Cruz Institute, Rio de Janeiro, Brazil., Silva PMRE; Laboratory of Inflammation, Oswaldo Cruz Institute, Rio de Janeiro, Brazil., Costa JCS; Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Martins MA; Laboratory of Inflammation, Oswaldo Cruz Institute, Rio de Janeiro, Brazil.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2020 Jul 30; Vol. 11, pp. 1159. Date of Electronic Publication: 2020 Jul 30 (Print Publication: 2020).